|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/18 | |
| A61P 3/10 |
| (11) | Patento numeris | 3062881 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14857066.6 |
| Europos patento paraiškos padavimo data | 2014-10-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-09-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-10-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/062378 |
| Data | 2014-10-27 |
| (87) | Numeris | WO 2015/065897 |
| Data | 2015-05-07 |
| (30) | Numeris | Data | Šalis |
| 201361896473 P | 2013-10-28 | US | |
| 201361922586 P | 2013-12-31 | US | |
| 201462067273 P | 2014-10-22 | US |
| (72) |
LING, Lei, US
|
| (73) |
NGM Biopharmaceuticals, Inc.,
333 Oyster Point Blvd., South San Francisco CA 94080,
US
|
| (54) | CANCER MODELS AND ASSOCIATED METHODS |
| CANCER MODELS AND ASSOCIATED METHODS |